by Impulse Dynamics | Jan 20, 2021 | News and Events, Press Releases
FDA Clears Potential Hurdle for Many Heart Failure Patients MARLTON, N.J., January 20, 2021 — Impulse Dynamics, a company dedicated to improving the lives of people with heart failure (HF), today announced the U.S. Food and Drug Administration (FDA) has approved the...
by Impulse Dynamics | Jan 12, 2021 | News and Events, Press Releases
Funding to Accelerate Clinical and Product Development Pipelines, Commercialization of Optimizer Smart System for Heart Failure MARLTON, N.J., January 12, 2021 — Impulse Dynamics, a company dedicated to helping healthcare providers improve the lives of people with...
by Impulse Dynamics | Jan 5, 2021 | Press Releases
Breakthrough Therapy Now Commercially Available in South America’s Most Populous Country MARLTON, N.J. – January 05, 2021 – Impulse Dynamics, a company dedicated to helping healthcare providers improve the lives of people with heart failure, today announced the first...
by Impulse Dynamics | Apr 14, 2020 | Press Releases
Availability of the two-lead device represents a significant advancement in the development of cardiac contractility modulation therapy for patients with heart failure MT. LAUREL, N.J.– April 14, 2020 – Impulse Dynamics, a medical device company dedicated to improving...
by Impulse Dynamics | Mar 17, 2020 | Press Releases
Post-Approval Study will evaluate real-world safety and efficacy evidence for breakthrough heart failure therapy MOUNT LAUREL, N.J. – March 17, 2020 Impulse Dynamics, Inc., a company dedicated to improving the lives of people with heart failure, today announced the...
by Impulse Dynamics | Mar 10, 2020 | Press Releases
Ishu Rao, M.D., brings wealth of clinical expertise during time of rapid company growth MOUNT LAUREL, N.J. – March 10, 2020 Impulse Dynamics, a company dedicated to improving the lives of people with heart failure and developer of the innovative CCM™ therapy delivered...
